203 related articles for article (PubMed ID: 11567995)
1. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.
Fukuda S; Pelus LM
Blood; 2001 Oct; 98(7):2091-100. PubMed ID: 11567995
[TBL] [Abstract][Full Text] [Related]
2. Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry.
Fukuda S; Pelus LM
Cell Cycle; 2002; 1(5):322-6. PubMed ID: 12461294
[TBL] [Abstract][Full Text] [Related]
3. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.
Fukuda S; Foster RG; Porter SB; Pelus LM
Blood; 2002 Oct; 100(7):2463-71. PubMed ID: 12239157
[TBL] [Abstract][Full Text] [Related]
4. [Expression of survivin in cord blood CD34(+) stem/progenitor cells and its significance].
Ma YP; Zou P; Xiao J; Huang SA
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):238-40. PubMed ID: 12859873
[TBL] [Abstract][Full Text] [Related]
5. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
6. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
7. Survivin as a cell cycle-related and antiapoptotic protein in granulosa cells.
Johnson AL; Langer JS; Bridgham JT
Endocrinology; 2002 Sep; 143(9):3405-13. PubMed ID: 12193553
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
[TBL] [Abstract][Full Text] [Related]
9. Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.
Chitteti BR; Liu Y; Srour EF
PLoS One; 2011 Mar; 6(3):e17498. PubMed ID: 21408179
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.
Chandele A; Prasad V; Jagtap JC; Shukla R; Shastry PR
Neoplasia; 2004; 6(1):29-40. PubMed ID: 15068669
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of umbilical cord blood CD34+ hematopoietic stem cells expansion with inhibition of TGF-β receptorII in co-culture with bone marrow mesenchymal stromal cells.
Sohrabi Akhkand S; Amirizadeh N; Nikougoftar M; Alizadeh J; Zaker F; Sarveazad A; Joghataei MT; Faramarzi M
Tissue Cell; 2016 Aug; 48(4):305-11. PubMed ID: 27344285
[TBL] [Abstract][Full Text] [Related]
12. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
13. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
14. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct.
Gotze KS; Ramirez M; Tabor K; Small D; Matthews W; Civin CI
Blood; 1998 Mar; 91(6):1947-58. PubMed ID: 9490677
[TBL] [Abstract][Full Text] [Related]
15. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
16. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
17. [The effect of down regulating of p27 on the activity of hematopoietic progenitor cells derived from umbilical cord blood and bone marrow ex vivo].
Li L; Li XX; Cheng T
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):90-3. PubMed ID: 15921625
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-regulated expression of survivin in myeloid leukemia.
Carter BZ; Milella M; Altieri DC; Andreeff M
Blood; 2001 May; 97(9):2784-90. PubMed ID: 11313272
[TBL] [Abstract][Full Text] [Related]
20. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
